Chem., Int. Ed., 2005, 44, 2324; (f) H. Ibrahim and A. Togni,
Chem. Commun., 2004, 1147; (g) R. Smits, C. D. Cadicamo,
K. Burger and B. Koksch, Chem. Soc. Rev., 2008, 37, 1727.
3 (a) E. J. Corey and A. Guzman-Perez, Angew. Chem., Int. Ed.,
1998, 37, 388; (b) J. Christoffers and A. Mann, Angew. Chem., Int.
Ed., 2001, 40, 4591; (c) I. Denissova and L. Barriault, Tetrahedron,
2003, 59, 10105; (d) J. Christoffers and A. Baro, Adv. Synth. Catal.,
2005, 347, 1473; (e) O. Riant and J. Hannedouche, Org. Biomol.
Chem., 2007, 5, 873; (f) P. G. Cozzi, R. Hilgraf and
N. Zimmermann, Eur. J. Org. Chem., 2007, 5969.
4 (a) L. Hintermann and A. Togni, Angew. Chem., Int. Ed., 2000, 39,
4359; (b) Y. Hamashima, K. Yagi, H. Takano, L. Tamas and
M. Sodeoka, J. Am. Chem. Soc., 2002, 124, 14530;
(c) Y. Hamashima, T. Suzuki, H. Takano, Y. Shimura and
M. Sodeoka, J. Am. Chem. Soc., 2005, 127, 10164;
(d) N. Shibata, J. Kohno, K. Takai, T. Ishimaru, S. Nakamura,
T. Toru and S. Kanemasa, Angew. Chem., Int. Ed., 2005, 44, 4204;
(e) D. S. Reddy, N. Shibata, J. Nagai, S. Nakamura, T. Toru and
S. Kanemasa, Angew. Chem., Int. Ed., 2008, 47, 164;
(f) M. Nakamura, A. Hajra, K. Endo and E. Nakamura, Angew.
Chem., Int. Ed., 2005, 44, 7248.
Scheme 1 Conversion of fluorinated Michael adduct to a chiral
pyrrolidine and lactam.
reduction and spontaneous cyclization led to the ready formation
of optically pure lactam 9.13
In summary, we have disclosed a highly enantioselective
organocatalytic generation of fluorinated quaternary stereogenic
centers adjacent to tertiary stereocenters, by employing
fluorine-containing methines as nucleophiles. We believe that
such an approach could complement the existing asymmetric
fluorination method to access a wide range of chiral fluorinated
molecules. Our results represent the first example in the
literature that a-fluorinated b-ketoesters were used as
nucleophiles, and highly functional, congested fluorinated
quaternary and chiral tertiary centers could be efficiently
constructed. Investigations to understand the origin of the
observed high enantioselectivity, and the full extension of the
scope of our approach employing fluorinated nucleophiles are
in progress in our laboratory, and will be reported in due
course.
5 D. Y. Kim and E. J. Park, Org. Lett., 2002, 4, 545.
6 S. Brandes, B. Niess, M. Bella, A. Prieto, J. Overgaard and
K. A. Jørgensen, Chem.–Eur. J., 2006, 12, 6039.
7 T. Ishimaru, N. Shibata, T. Horikawa, N. Yasuda, S. Nakamura,
T. Toru and M. Shiro, Angew. Chem., Int. Ed., 2008, 47, 4157.
8 (a) H. Li, Y. Wang, L. Tang, F. Wu, X. Liu, C. Guo,
B. M. Foxman and L. Deng, Angew. Chem., Int. Ed., 2005, 44,
105; (b) M. S. Taylor and E. N. Jacobsen, J. Am. Chem. Soc., 2003,
125, 11204; (c) J. F. Austin, S.-G. Kim, C. J. Sinz, W.-J. Xiao and
D. W. C. MacMillan, Proc. Natl. Acad. Sci. U. S. A., 2004, 101,
5482.
9 Chiral acyclic substituted b-ketoesters are rare in the literature. In
most cases, cyclic b-ketoesters were used as the substrates. For
selected examples, see ref. 8a, 10c and d.
10 For selective enantioselective organocatalytic reactions involving
b-ketoesters, see: (a) F. Wu, H. Li, R. Hong and L. Deng, Angew.
Chem., Int. Ed., 2006, 45, 947; (b) F. Wu, R. Hong, J. Khan, X. Liu
and L. Deng, Angew. Chem., Int. Ed., 2006, 45, 4301; (c) T. Okino,
Y. Hoashi, T. Furukawa, X. Xu and Y. Takemoto, J. Am. Chem.
Soc., 2005, 127, 119; (d) T. B. Poulsen, L. Bernardi, J. Aleman,
J. Overgaard and K. A. Jørgensen, J. Am. Chem. Soc., 2007, 129,
441.
We thank the National University of Singapore and the
Ministry of Education (MOE) of Singapore (R-143-000-
362-112) for generous financial support.
11 For a review on Cinchona alkaloid-based urea and thiourea
organocatalysts, see: S. J. Connon, Chem. Commun., 2008, 2499.
12 The extension of current methodology to a-fluorinated nitro esters
and a-fluorinated cyano esters was unsuccessful, no desired
products were formed under the same activation conditions.
13 For recent examples of constructing chiral pyrrolidines and lac-
tams, see: (a) T. A. Johnson, D. O. Jang, B. W. Slafer, M. D. Curtis
and P. Beak, J. Am. Chem. Soc., 2002, 124, 11689; (b) C. Najera,
M. G. Retamosa and J. M. Sansano, Angew. Chem., Int. Ed., 2008,
47, 6055.
Notes and references
1 For general reviews on fluorinated compounds in medicinal chem-
istry, see: (a) K. Muller, C. Faeh and F. Diederich, Science, 2007,
317, 1881; (b) K. L. Kirk, Org. Process Res. Dev., 2008, 12, 305.
2 For recent reviews, see: (a) K. Mikami, Y. Itoh and M. Yamanaka,
Chem. Rev., 2004, 104, 1; (b) V. A. Brunet and D. O’Hagan,
Angew. Chem., Int. Ed., 2007, 46, 1179; (c) G. K. S. Prakash and
P. Beier, Angew. Chem., Int. Ed., 2006, 45, 2172; (d) P. M. Pihko,
Angew. Chem., Int. Ed., 2006, 45, 544; (e) M. Oestreich, Angew.
ꢁc
This journal is The Royal Society of Chemistry 2009
2046 | Chem. Commun., 2009, 2044–2046